What is EtiraRx worth?
$45.0Mlast known valuation
EtiraRx last raised $2.3M in its Seed Round (Apr 2026).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for EtiraRx
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2026 | Seed Round | $2.3M | ▮ | ▮ |
| Jun 2025 | Seed Round | $2.4M | ▮ | ▮ |
| Sep 2023 | Seed Round | $4.8M | ▮ | ▮ |
How EtiraRx's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For EtiraRx, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is EtiraRx worth?
- EtiraRx's last known valuation is $45.0M.
- How much has EtiraRx raised?
- EtiraRx has raised $7.2M in total funding across 3 recorded rounds.
- When did EtiraRx last raise?
- EtiraRx last raised in Apr 2026 (Seed Round), raising $2.3M.